These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38567708)

  • 1. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
    Reyes-Hernández OD; Figueroa-González G; Quintas-Granados LI; Hernández-Parra H; Peña-Corona SI; Cortés H; Kipchakbayeva A; Mukazhanova Z; Habtemariam S; Leyva-Gómez G; Büsselberg D; Sharifi-Rad J
    Drug Dev Res; 2024 Apr; 85(2):e22175. PubMed ID: 38567708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
    Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
    Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma.
    Bailly C
    Chem Biol Interact; 2020 Jul; 325():109124. PubMed ID: 32437694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
    Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
    Front Immunol; 2021; 12():609295. PubMed ID: 33717093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers.
    Fan Y; Li S; Ding X; Yue J; Jiang J; Zhao H; Hao R; Qiu W; Liu K; Li Y; Wang S; Zheng L; Ye B; Meng K; Xu B
    BMC Cancer; 2019 Mar; 19(1):279. PubMed ID: 30922248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma.
    Lu Y; Gao Y; Yang H; Hu Y; Li X
    Mil Med Res; 2022 Dec; 9(1):69. PubMed ID: 36503490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells.
    Sun L; Peng Q; Qu L; Gong L; Si J
    Mol Med Rep; 2015 Apr; 11(4):3094-100. PubMed ID: 25434584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.
    Li S; Priceman SJ; Xin H; Zhang W; Deng J; Liu Y; Huang J; Zhu W; Chen M; Hu W; Deng X; Zhang J; Yu H; He G
    PLoS One; 2013; 8(12):e81657. PubMed ID: 24324713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma.
    Luo P; An Y; He J; Xing X; Zhang Q; Liu X; Chen Y; Yuan H; Chen J; Wong YK; Huang J; Gong Z; Du Q; Xiao W; Wang J
    Cancer Lett; 2024 Apr; 587():216621. PubMed ID: 38242198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.
    Yu Z; Guo J; Hu M; Gao Y; Huang L
    ACS Nano; 2020 Apr; 14(4):4816-4828. PubMed ID: 32188241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icaritin inhibits PD-L1 expression by Targeting Protein IκB Kinase α.
    Mo D; Zhu H; Wang J; Hao H; Guo Y; Wang J; Han X; Zou L; Li Z; Yao H; Zhu J; Zhou J; Peng Y; Li J; Meng K
    Eur J Immunol; 2021 Apr; 51(4):978-988. PubMed ID: 33354776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.
    He J; Wang Y; Duan F; Jiang H; Chen MF; Tang SY
    Planta Med; 2010 Nov; 76(16):1834-9. PubMed ID: 20560114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice.
    Hao H; Zhang Q; Zhu H; Wen Y; Qiu D; Xiong J; Fu X; Wu Y; Meng K; Li J
    Eur J Immunol; 2019 Dec; 49(12):2235-2244. PubMed ID: 31465113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Structure-Activity Analysis of Icaritin Derivatives as Potential Tumor Growth Inhibitors of Hepatocellular Carcinoma Cells.
    Li J; Shen S; Liu Z; Zhao H; Liu S; Liu Q; Yao GD; Song SJ
    J Nat Prod; 2023 Feb; 86(2):290-306. PubMed ID: 36745506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
    Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK
    Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of icaritin and the molecular mechanisms.
    Zhang C; Sui X; Jiang Y; Wang X; Wang S
    Discov Med; 2020; 29(156):5-16. PubMed ID: 32598859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis.
    Han H; Xu B; Hou P; Jiang C; Liu L; Tang M; Yang X; Zhang Y; Liu Y
    Cell Biochem Biophys; 2015 Jun; 72(2):533-42. PubMed ID: 25577511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.